Selected Grants
Phase II Randomized Trial comparing Percutaneous Ablation to Hypofractionaed Image Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocelluar Carcinoma Patients (PROVE-HCC)
Clinical TrialPrincipal Investigator · Awarded by Varian Medical Systems, Inc. · 2018 - 2026Inhibition of CaMKK2 sensitizes rectal cancers to radiation therapy
ResearchCollaborator · Awarded by National Institutes of Health · 2021 - 2022Knowledge-based Tutoring for Knowledge-based Radiation Therapy
ResearchCo Investigator · Awarded by Varian Medical Systems, Inc. · 2020 - 2022Clinical Experience Guided Reinforcement Learning for Pancreas SBRT
ResearchCollaborating Investigator · Awarded by Varian Medical Systems, Inc. · 2019 - 2022AN ADAPTIVE PHASE I/II DOSE ESCALATION TRIAL OF STEREOTACTIC BODY RADIATION THERAPY IN COMBINATION WITH RADIOMODULATING AGENT GC4419 IN LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA
Clinical TrialPrincipal Investigator · Awarded by Galera Therapeutics, Inc. · 2019 - 2021Motion Management Using 4D-MRI for Liver Cancer in Radiation Therapy
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2013 - 2016Biomarker Studies for Novel Anti-Cancer Agents
ResearchConsultant · Awarded by National Institutes of Health · 2003 - 2008External Relationships
- Oakstone Publishing CME
- UpToDate, Inc
- Varian Medical Systems
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.